Efficacy interferons bowenoid papulosis precancerous lesions Preliminary results open trial recombinant interferon gamma patients bowenoid papulosis Recombinant interferon gamma patients daily dose I.U injection patients treatment groups continuous therapy group subcutaneous injections week weeks intermittent block therapy group six-week cycles injections days cycle intermittent single-dose therapy group four-week cycles subcutaneous injection day cycle twenty-sixth week onset therapy complete responses patients treatment group whereas treatment groups patient results contrast acuminata bowenoid papulosis lesions interferon gamma injections 